Coincidentally, B7-H3 was shown to be stabilized by core fucosylation and the combination of fucosyltransferase inhibitor, 2F-Fuc, with anti-PDL1 resulted in enhanced therapeutic efficacy in B7-H3 positive triple negative breast cancer 78. This evidence concerns the gene CD274 and triple-negative breast carcinoma.